The near-term outlook for ClearPoint's biopharma business is also now clouded by FDA uncertainty around uniQure's AMT-130.
Johns Hopkins APL has installed a state-of-the-art robotic arm to advance repair and manufacturing for the maritime ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback